CLINICAL PATHOLOGY RESULTS

J.E.A. Leakey; W.T. Allaben; J.K. Dunnick; F.W. Lee; S.M. Lewis; P.C. Howard; C.C. Weis; D.D. Paine; S.M. Billedeau; B.R. Brown; J.P Freeman; J. Moody; L.K. Schoenbachler; P.H. Siitonen; S.J. Culp; J.M. Fowler; R.D. Smith; S. Appana; S.J. Baek; R.P. Felton; B.T. Thorn; C.J. Cain; J.W. Carson; A. Matson; K.A. Carroll; S.H. Green; P.W. Mellick; G.R. Olson; A.R. Warbritton; L.P. Wiley; M.H. Hamlin, II; J.F. Hardisty; R.A. Miller; J.F. Hardisty; J.M. Cullen; S.A. Elmore; D.E. Malarkey; P.W. Mellick; R.A. Miller; G.R. Olson; P.C. Howard; W.T. Allaben; N.J. Walker; J.R. Bucher; S.R. Gunnels; L.M. Harper; E.S. Rathman; D.C. Serbus

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Leakey JEA, Allaben WT, Dunnick JK, et al. NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet]. Research Triangle Park (NC): National Toxicology Program; 2013 Oct.

Cover of NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study)

NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53^tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet].

Show details

< Prev Next >

APPENDIX CCLINICAL PATHOLOGY RESULTS

Table C1. Hematology and Clinical Chemistry for Heterozygous F1 p53^+/− Mice in the 30-Week In Utero/Postnatal Gavage Study of AZT

Table C2. Hematology Data for Heterozygous F1 p53^+/− Mice at 160 Days in the 30- and 45-Week In Utero/Postnatal Gavage Studies of AZT

This is a work of the US government and distributed under the terms of the Public Domain

Bookshelf ID: NBK576206

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Leakey JEA, Allaben WT, Dunnick JK, et al. NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet]. Research Triangle Park (NC): National Toxicology Program; 2013 Oct. APPENDIX C, CLINICAL PATHOLOGY RESULTS.
PDF version of this title (3.1M)

Other titles in this collection

Genetically Modified Model Reports

Recent Activity

Clear Turn Off Turn On

CLINICAL PATHOLOGY RESULTS - NTP Genetically Modified Model Report on the Toxico...
CLINICAL PATHOLOGY RESULTS - NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study)

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet].

APPENDIX CCLINICAL PATHOLOGY RESULTS

Views

Other titles in this collection

Recent Activity

NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53^tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet].